Novo Nordisk is to freeze hiring in an effort to control costs at the drug maker. The halt will apply across all markets and ...

Novo Nordisk’s slower growth will crimp employee bonuses in the Ozempic maker’s... EU tariffs on Russian fertiliser imports that aim to cut funding for Moscow's war ...

Monksland-based global healthcare company Novo Nordisk has received planning permission to develop a temporary car park of ...

Drugmaker Novo Nordisk (NVO) will offer a reduced 2025 yearly bonus to its employees in Denmark due to the company’s lowered ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

No one stays on top forever. It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about. The Danish ...

Novo Nordisk's economic moat is eroding due to increased competition and US drug price pressures, but growth in international ...

Novo Nordisk, the maker of the blockbuster diabetes drug Ozempic, is at the center of a brewing legal storm. Once celebrated ...

The move is likely part of the company’s goal to reduce costs as it faces increased competition in the GLP-1 space.

Novo Nordisk faces potential layoffs after a period of rapid expansion fueled by the success of Wegovy. The company's ...

“Semaglutide has been in the US for more than eight years now. In India also, the oral version of this molecule is there for ...

BDCDA alerts traders in Karnataka on Novo Nordisk insulins & semiglutide injections’ pilferage in transit: Nandita ...